{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1","upperLimit":"91","value":"33"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"}],"units":"Participants"}],"description":"Tumor response rate according to Response Evaluation Criteria in Solid Tumors 1.1. Per Response Evaluation Criteria In Solid Tumors Criteria (RECIST v1.1) for target lesions and assessed by MRI: Complete Response (CR), Disappearance of all target lesions; Partial Response (PR), \\>=30% decrease in the sum of the longest diameter of target lesions; Overall Response (OR) = CR + PR.","dispersionType":"95% Confidence Interval","groups":[{"description":"Patients receive porfimer sodium IV over 3-5 minutes on day 0. Patients then undergo image-guided I-PDT on day 2.\n\nLaboratory Biomarker Analysis: Correlative studies\n\nPhotodynamic Therapy: Undergo image-guided I-PDT\n\nPorfimer Sodium: Given IV","id":"OG000","title":"Treatment (Porfimer Sodium, Image-guided I-PDT)"}],"paramType":"NUMBER","populationDescription":"All treated and eligible patients","reportingStatus":"POSTED","timeFrame":"Up to 12 months","title":"Percentage of Participants With Complete Response or Partial Response According to RECIST v1.1","type":"PRIMARY","unitOfMeasure":"percentage of participants"}